{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:33:27Z","timestamp":1790289207369,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"publisher","award":["VGFOUREG-660231"],"award-info":[{"award-number":["VGFOUREG-660231"]}],"id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centre for Antibiotic Resistance Research, University of Gothenburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s10096-018-3275-x","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T23:00:02Z","timestamp":1527030002000},"page":"1491-1497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Subsequent infection with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization"],"prefix":"10.1007","volume":"37","author":[{"given":"Anna","family":"Lindblom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Karami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"\u00c5hr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,23]]},"reference":[{"key":"3275_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JD Pitout","year":"2008","unstructured":"Pitout JD, Laupland KB (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:159\u2013166","journal-title":"Lancet Infect Dis"},{"key":"3275_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clinical Microbiol Rev 18:657\u2013686","journal-title":"Clinical Microbiol Rev"},{"key":"3275_CR3","unstructured":"World Health Organization (2014) Antimicrobial resistance - Global report on surveillance. Available from: \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/112642\/1\/9789241564748_eng.pdf?ua=1"},{"key":"3275_CR4","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/jac\/dkm318","volume":"60","author":"MJ Schwaber","year":"2007","unstructured":"Schwaber MJ, Carmeli Y (2007) Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60:913\u2013920","journal-title":"J Antimicrob Chemother"},{"key":"3275_CR5","first-page":"254","volume":"55","author":"M Melzer","year":"2007","unstructured":"Melzer M, Petersen I (2007) Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Inf Secur 55:254\u2013259","journal-title":"J Inf Secur"},{"key":"3275_CR6","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1128\/AAC.00143-10","volume":"54","author":"M Tumbarello","year":"2010","unstructured":"Tumbarello M, Spanu T, Di Bidino R, Marchetti M, Ruggeri M, Trecarichi EM, De Pascale G, Proli EM, Cauda R, Cicchetti A, Fadda G (2010) Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother 54:4085\u20134091","journal-title":"Antimicrob Agents Chemother"},{"key":"3275_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ijantimicag.2016.08.021","volume":"48","author":"M Alevizakos","year":"2016","unstructured":"Alevizakos M, Karanika S, Detsis M, Mylonakis E (2016) Colonisation with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents 48:647\u2013654","journal-title":"Int J Antimicrob Agents"},{"key":"3275_CR8","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2217\/fmb.12.100","volume":"7","author":"EM Trecarichi","year":"2012","unstructured":"Trecarichi EM, Cauda R, Tumbarello M (2012) Detecting risk and predicting patient mortality in patients with extended-spectrum beta-lactamase-producing Enterobacteriaceae bloodstream infections. Future Microbiol 7:1173\u20131189","journal-title":"Future Microbiol"},{"key":"3275_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s15010-014-0619-z","volume":"42","author":"D Vodovar","year":"2014","unstructured":"Vodovar D, Marcade G, Rousseau H, Raskine L, Vicaut E, Deye N, Baud FJ, Megarbane B (2014) Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization. Infection 42:743\u2013748","journal-title":"Infection"},{"key":"3275_CR10","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1086\/521260","volume":"45","author":"P Reddy","year":"2007","unstructured":"Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, Noskin GA, Zembower T (2007) Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect 45:846\u2013852","journal-title":"Clin Infect"},{"key":"3275_CR11","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/cid\/civ121","volume":"60","author":"WC Rottier","year":"2015","unstructured":"Rottier WC, Bamberg YR, Dorigo-Zetsma JW, van der Linden PD, Ammerlaan HS, Bonten MJ (2015) Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis. Clin Infect Dis 60:1622\u20131630","journal-title":"Clin Infect Dis"},{"key":"3275_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/cid\/ciw288","volume":"63","author":"SE Turbett","year":"2016","unstructured":"Turbett SE, Mansour MK (2016) Editorial commentary: fecal ESBL screening: are we ready for this information? Clin Infect Dis 63:319\u2013321","journal-title":"Clin Infect Dis"},{"key":"3275_CR13","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/AAC.01823-12","volume":"57","author":"L Armand-Lefevre","year":"2013","unstructured":"Armand-Lefevre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppe E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plesiat P, Andremont A (2013) Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 57:1488\u20131495","journal-title":"Antimicrob Agents Chemother"},{"key":"3275_CR14","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Available from: \n                    http:\/\/www.eucast.org\/clinical_breakpoints\/"},{"key":"3275_CR15","doi-asserted-by":"publisher","first-page":"e83030","DOI":"10.1371\/journal.pone.0083030","volume":"8","author":"N Karami","year":"2013","unstructured":"Karami N, Helldal L, Welinder-Olsson C, Ahren C, Moore ER (2013) Sub-typing of extended-spectrum-beta-lactamase-producing isolates from a nosocomial outbreak: application of a 10-loci generic Escherichia coli multi-locus variable number tandem repeat analysis. PLoS One 8:e83030","journal-title":"PLoS One"},{"key":"3275_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jhin.2013.04.018","volume":"84","author":"T Goulenok","year":"2013","unstructured":"Goulenok T, Ferroni A, Bille E, Lecuyer H, Join-Lambert O, Descamps P, Nassif X, Zahar JR (2013) Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization? J Hosp Infect 84:294\u2013299","journal-title":"J Hosp Infect"},{"key":"3275_CR17","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/jac\/dkl367","volume":"58","author":"JA Martinez","year":"2006","unstructured":"Martinez JA, Aguilar J, Almela M, Marco F, Soriano A, Lopez F, Balasso V, Pozo L, Mensa J (2006) Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia. J Antimicrob Chemother 58:1082\u20131085","journal-title":"J Antimicrob Chemother"},{"key":"3275_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00520-015-2772-z","volume":"24","author":"P Cornejo-Juarez","year":"2016","unstructured":"Cornejo-Juarez P, Suarez-Cuenca JA, Volkow-Fernandez P, Silva-Sanchez J, Barrios-Camacho H, Najera-Leon E, Velazquez-Acosta C, Vilar-Compte D (2016) Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies. Support Care Cancer 24:253\u2013259","journal-title":"Support Care Cancer"},{"key":"3275_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10096-010-1093-x","volume":"30","author":"M Arnan","year":"2011","unstructured":"Arnan M, Gudiol C, Calatayud L, Linares J, Dominguez MA, Batlle M, Ribera JM, Carratala J, Gudiol F (2011) Risk factors for, and clinical relevance of, faecal extended-spectrum beta-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microb Infect Dis 30:355\u2013360","journal-title":"Eur J Clin Microb Infect Dis"},{"key":"3275_CR20","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/jac\/dkw419","volume":"72","author":"S Ny","year":"2017","unstructured":"Ny S, Lofmark S, Borjesson S, Englund S, Ringman M, Bergstrom J, Naucler P, Giske CG, Byfors S (2017) Community carriage of ESBL-producing Escherichia coli is associated with strains of low pathogenicity: a Swedish nationwide study. J Antimicrob Chemother 72:582\u2013588","journal-title":"J Antimicrob Chemother"},{"key":"3275_CR21","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1099\/jmm.0.026963-0","volume":"60","author":"L Skjot-Rasmussen","year":"2011","unstructured":"Skjot-Rasmussen L, Hammerum AM, Jakobsen L, Lester CH, Larsen P, Frimodt-Moller N (2011) Persisting clones of Escherichia coli isolates from recurrent urinary tract infection in men and women. J Med Microbiol 60:550\u2013554","journal-title":"J Med Microbiol"},{"key":"3275_CR22","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1128\/JCM.44.5.1776-1781.2006","volume":"44","author":"K Ejrnaes","year":"2006","unstructured":"Ejrnaes K, Sandvang D, Lundgren B, Ferry S, Holm S, Monsen T, Lundholm R, Frimodt-Moller N (2006) Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women. J Clin Microbiol 44:1776\u20131781","journal-title":"J Clin Microbiol"},{"key":"3275_CR23","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1128\/AAC.02824-14","volume":"58","author":"R Banerjee","year":"2014","unstructured":"Banerjee R, Johnson JR (2014) A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother 58:4997\u20135004","journal-title":"Antimicrob Agents Chemother"},{"key":"3275_CR24","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/oxfordjournals.aje.a010170","volume":"151","author":"B Foxman","year":"2000","unstructured":"Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, Marsh JV, Spear S, Sobel JD, Marty MJ, Marrs CF (2000) Risk factors for second urinary tract infection among college women. Am J Epidemiol 151:1194\u20131205","journal-title":"Am J Epidemiol"},{"key":"3275_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2105\/AJPH.80.3.331","volume":"80","author":"B Foxman","year":"1990","unstructured":"Foxman B (1990) Recurring urinary tract infection: incidence and risk factors. Am J Public Health 80:331\u2013333","journal-title":"Am J Public Health"},{"key":"3275_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/clinids\/22.1.91","volume":"22","author":"R Ikaheimo","year":"1996","unstructured":"Ikaheimo R, Siitonen A, Heiskanen T, Karkkainen U, Kuosmanen P, Lipponen P, Makela PH (1996) Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 22:91\u201399","journal-title":"Clin Infect Dis"},{"key":"3275_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/003655400458767","volume":"32","author":"UM Karkkainen","year":"2000","unstructured":"Karkkainen UM, Ikaheimo R, Katila ML, Siitonen A (2000) Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up. Scand J Infect Dis 32:495\u2013499","journal-title":"Scand J Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3275-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3275-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3275-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T01:36:43Z","timestamp":1558575403000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3275-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,23]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["3275"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3275-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,23]]},"assertion":[{"value":"20 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and national and institutional regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the Regional Ethical Review Board in Gothenburg, Sweden (recordal: 170-17).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No informed consent was required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}